Strand Life Sciences

Decoding Genomics, Empowering Health.

Bengaluru, India · $23.0M raised

Headquarters
Bengaluru
Employees
201–500
Business Model
B2B
Total Funding
$23.0M
Last Round
$13.0M Series CFeb 2018
Rounds
9

About

Strand Life Sciences is a global genomics and bioinformatics company headquartered in Bangalore, India, with over 25 years of domain expertise and a team of more than 500 highly trained scientists, engineers, and bioinformaticians. The company works with customers in precision medicine to solve complex problems spanning engineering, bioinformatics, science, and translational medicine involving clinical and omics data. Strand's core offerings include NGS and PCR diagnostics applications, pharma and biomarker discovery services, and genomics software application development. The company generates single-cell and spatial transcriptomics data from clinical samples in its CAP-accredited India lab, curates omics data, and builds bioinformatics and tertiary analysis workflows. Strand has a 20-year track record building omics software products including GeneSpring, MassProfiler Professional, and StrandNGS. It is compliant with HIPAA and ISO 27001, and serves academic, pharmaceutical, biotechnology, and diagnostics sectors worldwide. Strand Life Sciences is a subsidiary of Reliance Industries Limited.

Summary

Strand Life Sciences is a Healthcare company based in Bengaluru, India. It has raised $23.0M in total across 9 rounds, most recently a $13.0M Series C round in Feb 2018. Investors include Quadria Capital, Biomark Capital and HealthQuad.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CFeb 2018
$13.0M

Sign up to see all 9 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies